255 related articles for article (PubMed ID: 26955964)
1. Application of Nanotechnology in the Diagnosis and Therapy of Hepatocellular Carcinoma.
Hou XY; Jiang G; Yang CS; Tang JQ; Wei ZP; Liu YQ
Recent Pat Anticancer Drug Discov; 2016; 11(3):322-31. PubMed ID: 26955964
[TBL] [Abstract][Full Text] [Related]
2. Magnetic Nanoparticles for Hepatocellular Carcinoma Diagnosis and Therapy.
Ungureanu BS; Teodorescu CM; Săftoiu A
J Gastrointestin Liver Dis; 2016 Sep; 25(3):375-83. PubMed ID: 27689203
[TBL] [Abstract][Full Text] [Related]
3. Nanotheranostics: Their role in hepatocellular carcinoma.
Malla RR; Kumari S; Kgk D; Momin S; Nagaraju GP
Crit Rev Oncol Hematol; 2020 Jul; 151():102968. PubMed ID: 32416345
[TBL] [Abstract][Full Text] [Related]
4. Nanoparticles for targeted delivery of therapeutics and small interfering RNAs in hepatocellular carcinoma.
Varshosaz J; Farzan M
World J Gastroenterol; 2015 Nov; 21(42):12022-41. PubMed ID: 26576089
[TBL] [Abstract][Full Text] [Related]
5. Recent advances in hepatocellular carcinoma-targeted nanoparticles.
Liu X; Bai Y; Zhou B; Yao W; Song S; Liu J; Zheng C
Biomed Mater; 2024 May; 19(4):. PubMed ID: 38697209
[TBL] [Abstract][Full Text] [Related]
6. Nanomedicine in management of hepatocellular carcinoma: Challenges and opportunities.
Mohamed NK; Hamad MA; Hafez MZ; Wooley KL; Elsabahy M
Int J Cancer; 2017 Apr; 140(7):1475-1484. PubMed ID: 27861850
[TBL] [Abstract][Full Text] [Related]
7. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
8. Non-surgical treatment of hepatocellular carcinoma (HCC).
Fevery J
Acta Gastroenterol Belg; 2000; 63(2):233-5. PubMed ID: 10925476
[No Abstract] [Full Text] [Related]
9. Hepatocellular carcinoma: Advances in diagnostic imaging.
Sun H; Song T
Drug Discov Ther; 2015 Oct; 9(5):310-8. PubMed ID: 26632539
[TBL] [Abstract][Full Text] [Related]
10. The medical management of hepatocellular carcinoma (HCC) in Japan: a review with implications for HCC seen in the west.
Ichida T; Van Thiel DH; Hassanein T
Hepatogastroenterology; 1996; 43(12):1575-83. PubMed ID: 8975968
[TBL] [Abstract][Full Text] [Related]
11. [Research advances in diagnostic and therapeutic application of long-chain non-coding RNAs in hepatocellular carcinoma].
Li WX; Li Q; Lin Y; Huang YX; Chen L
Zhonghua Gan Zang Bing Za Zhi; 2016 Aug; 24(8):628-631. PubMed ID: 27788714
[TBL] [Abstract][Full Text] [Related]
12. Nanomedicine as a putative approach for active targeting of hepatocellular carcinoma.
Elnaggar MH; Abushouk AI; Hassan AHE; Lamloum HM; Benmelouka A; Moatamed SA; Abd-Elmegeed H; Attia S; Samir A; Amr N; Johar D; Zaky S
Semin Cancer Biol; 2021 Feb; 69():91-99. PubMed ID: 31421265
[TBL] [Abstract][Full Text] [Related]
13. Current status of nanomaterial-based treatment for hepatocellular carcinoma.
Baig B; Halim SA; Farrukh A; Greish Y; Amin A
Biomed Pharmacother; 2019 Aug; 116():108852. PubMed ID: 30999152
[TBL] [Abstract][Full Text] [Related]
14. Nanotargeted agents: an emerging therapeutic strategy for breast cancer.
Du M; Ouyang Y; Meng F; Ma Q; Liu H; Zhuang Y; Pang M; Cai T; Cai Y
Nanomedicine (Lond); 2019 Jul; 14(13):1771-1786. PubMed ID: 31298065
[TBL] [Abstract][Full Text] [Related]
15. Advances in liver-directed gene therapy for hepatocellular carcinoma by non-viral delivery systems.
Ding B; Li T; Zhang J; Zhao L; Zhai G
Curr Gene Ther; 2012 Apr; 12(2):92-102. PubMed ID: 22348553
[TBL] [Abstract][Full Text] [Related]
16. Insights into Nanotherapeutic Strategies as an Impending Approach to Liver Cancer Treatment.
Singh A; Shafi S; Upadhyay T; Najmi AK; Kohli K; Pottoo FH
Curr Top Med Chem; 2020; 20(20):1839-1854. PubMed ID: 32579503
[TBL] [Abstract][Full Text] [Related]
17. Surface Engineering of Nanoparticles for Targeted Delivery to Hepatocellular Carcinoma.
Lu J; Wang J; Ling D
Small; 2018 Feb; 14(5):. PubMed ID: 29251419
[TBL] [Abstract][Full Text] [Related]
18. Use of Nanotechnology in Diagnosis and Treatment of Hepatic Fibrosis: A Review.
Taymouri S; Taheri A
Curr Drug Deliv; 2016; 13(5):662-72. PubMed ID: 26343151
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant therapy for hepatocellular carcinoma: current situation and prospect.
Wang Z; Zhang G; Wu J; Jia M
Drug Discov Ther; 2013 Aug; 7(4):137-43. PubMed ID: 24071575
[TBL] [Abstract][Full Text] [Related]
20. Nanomedicines reveal how PBOV1 promotes hepatocellular carcinoma for effective gene therapy.
Guo Y; Wu Z; Shen S; Guo R; Wang J; Wang W; Zhao K; Kuang M; Shuai X
Nat Commun; 2018 Aug; 9(1):3430. PubMed ID: 30143633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
